Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.
AUTOR(ES)
Rio, M C
RESUMO
The expression of the pS2 gene, which is induced by estrogen in the breast cancer cell line MCF-7, has been investigated in breast cancers by using pS2 mRNA determination in tumor specimens and immunocytochemistry to identify pS2 protein in paraffin-embedded sections. Using these assays we show that determination of pS2 gene expression allows the definition of subclasses of estrogen-receptor-containing breast cancers that may be used to more precisely identify estrogen-dependent tumors. Tumor specimens have also been analyzed for the presence of mRNAs for the estrogen receptor and for the ERBB2 oncogene. No evidence for the presence of truncated forms of estrogen-receptor mRNA has been found, and overexpression of the ERBB2 oncogene did not correlate with the steroid receptor status or pS2 gene expression.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=299729Documentos Relacionados
- hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma.
- Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence.
- Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.
- Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7.
- Expression of pS2 in prostate cancer correlates with grade and Chromogranin A expression but not with stage